Aspects of Software to Monitor Myeloma Patients

Tuesday, August 6, 6 – 7:30 p.m.
Anaheim Marriott, Platinum Ballroom 3
Supported by Helena Laboratories


Protein electrophoresis and immunofixation (IFE) have been relied upon to aid in the detection and monitoring of plasma cell dyscrasia for many years. Interpretation of protein and IFE patterns will be discussed. New approaches to myeloma treatment can sometimes alter the presentation of patterns. Strategies for accurate interpretation will be offered. The importance of gauging the efficacy of treatment will be reviewed. Myeloma tracking software allows for more comprehensive monitoring of treatment in myeloma patients.


Attendees will:

  • Learn the important points in interpretation of protein and IFE patterns.
  • Understand the implications of new therapies for protein and IFE patterns.
  • Understand the utility of software to monitor the progression of therapy for myeloma patients.


Robert S. Galen, MD, MPH
Professor Emeritus
College of Public Health-University of Georgia
Athens, GA


Douglas Kingma, MD
Medical Director
Tennessee Oncology
Nashville, TN